Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Medulloblastoma, the most common pediatric malignant brain tumor, continues to have a high rate of morbidity and mortality in childhood. Recent advances in cancer genomics, single-cell sequencing, and sophisticated tumor models have revolutionized the characterization and stratification of medullobl...
Main Authors: | Han Zou, Brad Poore, Alberto Broniscer, Ian F. Pollack, Baoli Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/643 |
Similar Items
-
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score
by: Xinlong Zheng, et al.
Published: (2024-03-01) -
Advances in Immunohistochemical Markers in Molecular Classification of Medulloblastoma
by: ZHAO Hongyu, et al.
Published: (2018-04-01) -
Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23
by: Peter Hau, et al.
Published: (2021-07-01) -
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
by: Liana Nobre, et al.
Published: (2020-06-01) -
Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods
by: Joo Whan Kim, et al.
Published: (2022-11-01)